Investment company Amanat Holdings appoints two new senior figures to its board

By Catherine Sturman
The GCC’s largest healthcare and education investment company, Amanat Holdings, has appointed new chairman, Hamad Abdulla Alshamsi and Dr Vayalil as i...

The GCC’s largest healthcare and education investment company, Amanat Holdings, has appointed new chairman, Hamad Abdulla Alshamsi and Dr Vayalil as its new Vice Chairman and Managing Director.

Selected by the board, both will work to further the companies ambitions to drive the UAE’s healthcare sector and cater to international markets in order to not only remain competitive, but become a centre of excellence in both healthcare and education.

“With increased demand for quality healthcare and education services in the GCC, the time is very opportune for the private sector to play a growing role in its contribution to these sectors,” explained chairman Faisal Belhoul. “With our long term and collaborative investment approach we are well positioned to capitalise on these opportunities.”

Related stories

Resulting in partnerships with businesses in Saudi Arabia and the UAE, Amanat Holdings third quarter figures have increased by over 10%, which is set to increased further through new investments in its fourth quarter.

“Amanat has the potential to become a game changer in healthcare and education, not only in the UAE but on the global stage,” commented Dr Vayalil.

“Both sectors are ripe for investment and with Amanat’s strong financial position, now is the time to implement a strategic and ambitious financial deployment plan that will unlock further value for shareholders. I look forward to playing an active role in driving the business forward at this exciting time.”

 

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare